The DOI matches its Crossref record; 2 of the 2 references it cites were found in a registry or an index.
Gold Nanoparticles Enhance the Anti-Leukemia Action of a 6-Mercaptopurine Chemotherapeutic Agent
Abstract
6-mercaptopurine and its riboside derivatives are some of the most widely utilized anti-leukemic and anti-inflammatory drugs. Their short biological half-life and severe side effects limit their use. A new delivery method for these drugs based on 4-5 nm gold nanoparticles can potentially resolve these issues. We have found substantial enhancement of the antiproliferative effect against K-562 leukemia cells of Au nanoparticles bearing 6-mercaptopurine-9-beta-d-ribofuranoside compared to the same drug in typically administered free form. The improvement was attributed to enhanced intracellular transport followed by the subsequent release in lysosomes. Enhanced activity and nanoparticle carriers will make possible the reduction of the overall concentration of the drug, renal clearance, and, thus, side effects. The nanoparticles with mercaptopurine also showed excellent stability over 1 year without loss of inhibitory activity.
Overview
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Pacher, P., Nivorozhkin, A., & Szabó, C. (2006) · Pharmacological Reviews · doi:10.1124/pr.58.1.6 · Cited by 1,218
Parameters influencing the stealthiness of colloidal drug delivery systems
Vonarbourg, A., Passirani, C., Saulnier, P., & Benoit, J.-P. (2006) · Biomaterials · doi:10.1016/j.biomaterials.2006.03.039 · Cited by 740
Cited by
Gold nanoparticles in nanomedicine: preparations, imaging, diagnostics, therapies and toxicity
Boisselier, E., & Astruc, D. (2009) · Chemical Society Reviews · doi:10.1039/b806051g · Cited by 2,842
Gold nanoparticles in biomedical applications: recent advances and perspectives
Dykman, L., & Khlebtsov, N. (2012) · Chem. Soc. Rev. · doi:10.1039/c1cs15166e · Cited by 1,961
Gold nanoparticles: preparation, properties, and applications in bionanotechnology
Yeh, Y.-C., Creran, B., & Rotello, V. M. (2012) · Nanoscale · doi:10.1039/c1nr11188d · Cited by 1,346
Liposomes and nanoparticles: nanosized vehicles for drug delivery in cancer
Malam, Y., Loizidou, M., & Seifalian, A. M. (2009) · Trends in Pharmacological Sciences · doi:10.1016/j.tips.2009.08.004 · Cited by 1,318
The unique role of nanoparticles in nanomedicine: imaging, drug delivery and therapy
Doane, T. L., & Burda, C. (2012) · Chemical Society Reviews · doi:10.1039/c2cs15260f · Cited by 1,098
Surface plasmons in metallic nanoparticles: fundamentals and applications
Garcia, M. A. (2011) · Journal of Physics D: Applied Physics · doi:10.1088/0022-3727/44/28/283001 · Cited by 907
Gold Nanoparticles in Cancer Treatment
Sztandera, K., Gorzkiewicz, M., & Klajnert-Maculewicz, B. (2019) · Molecular Pharmaceutics · doi:10.1021/acs.molpharmaceut.8b00810 · Cited by 607
Hu, X., Zhang, Y., Ding, T., Liu, J., & Zhao, H. (2020) · Frontiers in Bioengineering and Biotechnology · doi:10.3389/fbioe.2020.00990 · Cited by 546
pH-Induced Aggregation of Gold Nanoparticles for Photothermal Cancer Therapy
Nam, J., Won, N., Jin, H., Chung, H., & Kim, S. (2009) · Journal of the American Chemical Society · doi:10.1021/ja902062j · Cited by 542
Gold nanoparticle platforms as drug and biomacromolecule delivery systems
Duncan, B., Kim, C., & Rotello, V. M. (2010) · Journal of Controlled Release · doi:10.1016/j.jconrel.2010.06.004 · Cited by 469
A repertoire of biomedical applications of noble metal nanoparticles
Azharuddin, M., Zhu, G. H., Das, D., Ozgur, E., Uzun, L., Turner, A. P. F., & Patra, H. K. (2019) · Chemical Communications · doi:10.1039/c9cc01741k · Cited by 395
Gold nanoparticles: From nanomedicine to nanosensing
Oyelere, A. (2008) · Nanotechnology, Science and Applications · doi:10.2147/nsa.s3707 · Cited by 350
Jin, H., Heller, D. A., & Strano, M. S. (2008) · Nano Letters · doi:10.1021/nl072969s · Cited by 330
Nanotechnology for Early Cancer Detection
Choi, Y.-E., Kwak, J.-W., & Park, J. W. (2010) · Sensors · doi:10.3390/s100100428 · Cited by 329
Emerging advances in nanomedicine with engineered gold nanostructures
Webb, J. A., & Bardhan, R. (2014) · Nanoscale · doi:10.1039/c3nr05112a · Cited by 324
Regiospecific Plasmonic Assemblies for in Situ Raman Spectroscopy in Live Cells
Xu, L., Kuang, H., Xu, C., Ma, W., Wang, L., & Kotov, N. A. (2012) · Journal of the American Chemical Society · doi:10.1021/ja2088713 · Cited by 274
Self-citationMultimodal drug delivery using gold nanoparticles
Kim, C.-K., Ghosh, P., & Rotello, V. M. (2009) · Nanoscale · doi:10.1039/b9nr00112c · Cited by 267
Formation of the Protein Corona: The Interface between Nanoparticles and the Immune System
Barbero, F., Russo, L., Vitali, M., Piella, J., Salvo, I., Borrajo, M. L., Busquets-Fité, M., Grandori, R., Bastús, N. G., Casals, E., et al. (2017) · Seminars in Immunology · doi:10.1016/j.smim.2017.10.001 · Cited by 263
Exosome-like Nanoparticles: A New Type of Nanocarrier
Fernandes, M., Lopes, I., Teixeira, J., Botelho, C., & Gomes, A. C. (2020) · Current Medicinal Chemistry · doi:10.2174/0929867326666190129142604 · Cited by 51
Metadata
- Authors
- Podsiadlo, P., Sinani, V. A., Bahng, J. H., Kam, N. W. S., Lee, J., & Kotov, N. A.
- Venue
- Langmuir
- Publisher
- American Chemical Society (ACS)
- Published
- 2007-12-05
- Volume
- 24
- Issue
- 2
- Pages
- 568-574
- ISSN
- 0743-7463 (ISSN-L)
- 1520-5827
- OpenAlex
- W2050019054
- Cited by
- 213
- References
- 2
- FWCI
- 5.14
- Type
- journal article
- Language
- en
- Open access
- closed
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.